Redx Pharma (REDX)

Sector:

Pharma and Biotech

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

14.25p
   
  • Change Today:
      0.25p
  • 52 Week High: 40.00
  • 52 Week Low: 13.65
  • Currency: UK Pounds
  • Shares Issued: 126.48m
  • Volume: 65,391
  • Market Cap: 18.02m
  • RiskGrade: 343

Redx Pharma Overview

Redx Pharma is in the pharma and biotech sector and is currently trading at 14.25p per share. In the last year Redx Pharma's share price has ranged from 13.65p to 40.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart (21-02-2018)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 6.5% n/a
ROCE 8.9%  
Latest F'cast
P/E 10.2 n/a
PEG n/a n/a
Pr/Revenue 0.6 n/a
Pr/Book 1.3  
Latest F'cast
Revenue n/a -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Redx Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-14 n/a (4.26) (7.60)p n/a n/a n/a n/a 0.0%
30-Sep-15 n/a (8.82) (14.10)p n/a n/a n/a n/a 0.0%
30-Sep-16 n/a (15.41) (19.80)p n/a n/a n/a n/a 0.0%
30-Sep-17 30.47 1.65 1.40p 23.1 n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Redx Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-18 n/a (11.32) (8.20)p n/a n/a n/a n/a 0.0%
30-Sep-19 n/a (13.83) (8.80)p n/a n/a n/a n/a 0.0%

Copyright © 2018 FactSet Research Systems Inc. All rights reserved.

Latest Redx Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Redx Pharma Market Data

Currency UK Pounds
Share Price 14.25p
Change Today 0.25p
% Change 1.79 %
52 Week High 40.00
52 Week Low 13.65
Volume 65,391
Shares Issued 126.48m
Market Cap 18.02m
RiskGrade 343

Redx Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.14% above the market average38.14% above the market average38.14% above the market average38.14% above the market average38.14% above the market average
80.33% above the sector average80.33% above the sector average80.33% above the sector average80.33% above the sector average80.33% above the sector average
Price Trend
94.02% below the market average94.02% below the market average94.02% below the market average94.02% below the market average94.02% below the market average
84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average84.62% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Redx Pharma Dividends

No dividends found

Trades for 21-Feb-2018

Time Volume / Share Price
14:51 18,304 @ 13.65p
14:08 25,000 @ 13.80p
13:46 1,500 @ 14.25p
13:39 1,854 @ 13.80p
12:39 10,530 @ 14.15p

Redx Pharma Key Personnel

CFO Dominic Jackson

Top of Page